Correspondence 0001437749-23-029188 from BIO KEY INTERNATIONAL INC (BKYI)
BIO KEY INTERNATIONAL INC
Date: Oct. 27, 2023 · CIK: 0001019034 · Accession: 0001437749-23-029188
AI Filing Summary & Sentiment
File numbers found in text: 333-275003
Show Raw Text
CORRESP 1 filename1.htm bkyi20231027c_corresp.htm October 27, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-1004 Re: BIO-key International, Inc. Registration Statement on Form S-1, as amended File No. 333-275003 Ladies and Gentlemen: As the placement agent of the proposed offering of BIO-key International, Inc. (the “Company”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 9:00 a.m., Eastern Time, on Monday, October 30, 2023, or as soon thereafter as is practicable. Pursuant to Rule 460 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, we wish to advise you that, through October 27, 2023, we distributed to each dealer, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies, as well as “E-red” copies of the Preliminary Prospectus dated October 26, 2023, as appears to be reasonable to secure adequate distribution of the preliminary prospectus. The undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. Very truly yours, Maxim Group LLC By: /s/ Clifford A. Teller Name: Clifford A. Teller Title: Co-President